An AdventHealth team reports that plasma-derived extracellular vesicle (EV) proteomics can distinguish partial clinical remission (PCR) in new-onset type 1
A team from Boston and Tampa proposes ‘Time to Minimum Residual C-Peptide’ (TMRCP), a longitudinal endpoint that captures the trajectory
This study was presented as part of the session “Diabetes and Heart Talk” on June 23rd, 2025, during the 85th
This study was presented on June 23rd, 2025, during the 85th ADA Scientific Sessions held in Chicago, IL. A groundbreaking
This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity”
This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at
This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity”
This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at
This paper was presented as a part of the session “Dropping Cost and Complications—CVD Risk and DM—SGLT2s and GLPs for
This paper was presented as a part of the session “The Tidal Wave Is Coming—Heart Failure Diagnosis, Prevention, and Treatment